A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation. [electronic resource]
- The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
- 32-8 p. digital